Skip to content

Drug interactions

Eliglustat + Glibenclamide

Severity: Minor

Eliglustat and Glibenclamide: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Eliglustat inhibits P-glycoprotein and may raise concentrations of P-gp substrates. Glyburide exposure could increase, with a greater risk of hypoglycemia.

What this interaction means in plain words

Eliglustat and Glibenclamide have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Eliglustat belongs to Miscellaneous; Glibenclamide belongs to Endocrine.

Evidence level: Low

Why it happens

Inhibition of intestinal P-glycoprotein efflux by eliglustat increases glyburide absorption.

What to do

Monitor blood glucose when eliglustat is started and reduce the glyburide dose if hypoglycemia occurs.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Eliglustat and Glibenclamide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Eliglustat with Glibenclamide?

MediHelp rates the interaction as minor. Eliglustat and Glibenclamide have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Eliglustat inhibits P-glycoprotein and may raise concentrations of P-gp substrates. Glyburide exposure could increase, with a greater risk of hypoglycemia.

How serious is the interaction between Eliglustat and Glibenclamide?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood glucose when eliglustat is started and reduce the glyburide dose if hypoglycemia occurs.

What other medicines interact with Glibenclamide?

MediHelp also lists interactions of Glibenclamide with, for example, Bosentan, Cholic acid, Ciprofloxacin. The full list is on the Glibenclamide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in